Sekine, Masayuki
Enomoto, Takayuki
Arai, Masami
Yokoyama, Shiro
Nomura, Hiroyuki
Nishino, Koji
Ikeuchi, Takeshi http://orcid.org/0000-0001-8828-8085
Kuriyama, Yoko
Nakamura, Seigo
Nomizu, Tadashi
Sakurai, Akihiro
Okawa, Megumi
Yotsumoto, Junko
Kumamaru, Hiraku
Shimoda, Miyuki
,
Article History
Received: 9 October 2021
Accepted: 29 November 2021
First Online: 4 January 2022
Competing interests
: M.S. received lecture fees from AstraZeneca. T.E. received lecture fees from AstraZeneca and Chugai Pharmaceutical. S.N. received lecture fees from AstraZeneca and KONICA MINOLTA. Other authors declare no competing interests.
: The ethics review board of the Japanese HBOC Consortium approved the establishment of the database to investigate Japanese HBOC patients’ characteristics. This registration has been begun after obtaining further approval from the institutional review board of each medical institution where <i>BRCA</i> genetic testing and genetic counseling were available.